0
Abstract: Slide Presentations |

GLUCOCORTICOSTEROIDS PREVENT THE PRO-ASTHMATIC EFFECTS OF PROLONGED EXPOSURE TO A LONG-ACTING BETA2-ADRENOCEPTOR AGONIST IN AIRWAY SMOOTH MUSCLE (ASM) BY MODULATING PHOSPHODIESTERASE 4 (PDE4) ACTIVITY FREE TO VIEW

Gustavo Nino, MD*; Aihua Hu, PhD; Judith Grunstein, MA; Michael Grunstein, MD
Author and Funding Information

Children’s Hospital of Philadelphia, Philadelphia, PA


Chest


Chest. 2008;134(4_MeetingAbstracts):s23002. doi:10.1378/chest.134.4_MeetingAbstracts.s23002
Text Size: A A A
Published online

Abstract

PURPOSE:Use of long-acting ×2AR agonists to treat asthma has been associated with bronchoconstrictor hyperresponsiveness, impaired ×2AR-mediated airway relaxation and worsening of the asthmatic condition, phenomena potentially reflecting the effects of prolonged homologous ×2AR desensitization (tolerance) in ASM. We recently demonstrated that upregulated PDE4 activity mediates pro-asthmatic changes in ASM function induced by prolonged ASM exposure to cAMP-elevating agents. Since the deleterious effects of long-acting ×2AR agonists are reportedly mitigated when using these agents in combination with glucocorticoids (GCs), we examined whether GCs attenuate the pro-asthmatic effects of ASM exposure to a long-acting ×2AR agonist, and whether this GC action is attributed to altered regulation of PDE4 activity.

METHODS:Isolated rabbit ASM tissues and cultured human ASM (HASM) cells were exposed to the long-acting ×2AR agonist, salmeterol (SAL; 10 αM × 24 hr) in the absence and presence of pretreatment with either the PDE4 inhibitor, rolipram (10 αM), or dexamethasone (1 αM). The tissues were then examined for altered constrictor and relaxation responsiveness to acetylcholine (ACh) and isoproterenol (ISO), respectively, and the HASM cells were examined for induced changes in PDE4 activity.

RESULTS:The data demonstrated that: 1) SAL-exposed ASM tissues exhibited markedly impaired relaxation responses to ISO and increased constrictor responses to ACh; 2) SAL-exposed HASM cells exhibited significantly increased cAMP PDE activity; and 3) both these changes in constrictor and relaxation responsiveness and increase in PDE4 activity were prevented by pretreating SAL-exposed ASM with either rolipram or dexamethasone.

CONCLUSION:Taken together, these novel data demonstrate that GCs prevent the induction of PDE4-mediated pro-asthmatic-like changes in ASM responsiveness that is associated with prolonged exposure of ASM to a long-acting ×2AR agonist.

CLINICAL IMPLICATIONS:Accordingly, these findings identify a mechanism that potentially accounts for the role of glucocorticosteroids in ameliorating the deleterious effects of prolonged exposure of the airways to long-acting ×2AR agonists.

DISCLOSURE:Gustavo Nino, No Financial Disclosure Information; No Product/Research Disclosure Information

Monday, October 27, 2008

2:30 PM - 4:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
Guidelines
Management of asthma.
Singapore Ministry of Health | 7/18/2008
Adapting your practice: treatment and recommendations for homeless patients with asthma.
National Health Care for the Homeless Council, Inc. | 6/13/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543